You have 9 free searches left this month | for more free features.

Condition

Dyslipidemias (2)

Hyperlipoproteinemia (1)

Lipid Metabolism Disorders (1)

Metabolic Diseases (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Eli Lilly and Company (2)

Collaborator

Intervention

ly3561774 (2)

placebo (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ly3561774

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Dyslipidemias Trial in United States (LY3561774, Placebo)

Completed

Dyslipidemias

LY3561774
Placebo

Cypress, California
+4 more

Aug 9, 2022

Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases Trial in Worldwide (LY3561774, Placebo)

Recruiting

Dyslipidemias
+3 more

LY3561774
Placebo

Waterbury, Connecticut
+40 more

Aug 17, 2022